0001104659-21-059120.txt : 20210430 0001104659-21-059120.hdr.sgml : 20210430 20210430164758 ACCESSION NUMBER: 0001104659-21-059120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210428 FILED AS OF DATE: 20210430 DATE AS OF CHANGE: 20210430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gelone Steven P. CENTRAL INDEX KEY: 0001693064 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 21879055 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 tm2112537-4_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-04-28 0 0001641640 Nabriva Therapeutics plc NBRV 0001693064 Gelone Steven P. 414 COMMERCE DR. SUITE 120 FORT WASHINGTON PA 19034 1 1 0 0 President and COO Ordinary Shares 2021-04-28 4 A 0 290697 0 A 367437 D The reported transaction involved the reporting person's receipt of a grant of 290,697 restricted stock units. The total reported in Column 5 includes the 290,697 newly awarded restricted stock units. /s/ Robert Crotty, by power of attorney 2021-04-30